PCSK9 and COVID-19: Since statins reduce inflammation but also increase the transcription of the PCSK9 gene [57] as well as the circulating levels of the protein [58], it would be informative to measure plasma PCSK9 levels in COVID-19 patients taking or not taking statins and correlate them with disease severity and hospitalization status.